Last reviewed · How we verify

AI201901 — Competitive Intelligence Brief

AI201901 (AI201901) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Unknown. Area: Unknown.

phase 3 Unknown Unknown Unknown Small molecule Live · refreshed every 30 min

Target snapshot

AI201901 (AI201901) — Abdi Ibrahim Ilac San. ve Tic A.S.. AI201901 is a small molecule drug that targets the molecular target.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
AI201901 TARGET AI201901 Abdi Ibrahim Ilac San. ve Tic A.S. phase 3 Unknown Unknown
SINECATECHINS SINECATECHINS marketed Polyphenols Unknown 2006-01-01
PODOFILOX PODOFILOX marketed Topical antiviral Unknown 1990-01-01
POLIDEXIDE SULFATE POLIDEXIDE SULFATE marketed Unknown Unknown 1974-01-01
SUTILAINS SUTILAINS marketed Unknown Unknown 1969-01-01
Pf-08032562 pf-08032562 Pfizer Inc. marketed unknown unknown
Latanoprost plus adjunctive glaucoma medication Latanoprost plus adjunctive glaucoma medication Sight Sciences, Inc. marketed Prostaglandin analog with adjunctive glaucoma agent FP prostaglandin receptor (latanoprost component); adjunctive target unknown

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Unknown class)

  1. Pfizer · 24 drugs in this class
  2. · 2 drugs in this class
  3. Ahn-Gook Pharmaceuticals Co.,Ltd · 1 drug in this class
  4. Beijing Tiantan Hospital · 1 drug in this class
  5. Bursa Yuksek Ihtisas Training and Research Hospital · 1 drug in this class
  6. Dongkook Pharmaceutical Co., Ltd. · 1 drug in this class
  7. GlaxoSmithKline · 1 drug in this class
  8. Gloucestershire Hospitals NHS Foundation Trust · 1 drug in this class
  9. Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · 1 drug in this class
  10. Jiangsu HengRui Medicine Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). AI201901 — Competitive Intelligence Brief. https://druglandscape.com/ci/ai201901. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: